Synergistic antitumor effect of anti-PDL1 combined with oxaliplatin on a mouse tumor model

被引：0
|
作者：
Rahimi, A. [1 ]
Alimohammadi, R. [2 ]
Jalali, S. A. [2 ]
Golchin, S. [2 ]
机构：
[1] Tarbiat Modares Univ, Immunol, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Immunol, Tehran, Iran
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
LB070
引用
收藏
页码：1735 / 1736
页数：2
相关论文
共 50 条
  • [1] Synergistic antitumor effect of anti-PD-L1 combined with oxaliplatin on a mouse tumor model
    Golchin, Soheila
    Alimohammadi, Reza
    Nejad, Mohammad Rostami
    Jalali, Seyed Amir
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) : 19866 - 19874
  • [2] Deciphering anti-PDL1 effect in a syngeneic mouse model of sarcoma
    Nafia, Imane
    Chaibi, Assia
    Bortolotto, Doriane
    Rey, Christophe
    Italiano, Antoine
    Bessede, Alban
    CANCER RESEARCH, 2020, 80 (16)
  • [3] COMPREHENSIVE ANALYSIS OF A NOVEL ANTI-PDL1 RESISTANT SARCOMA MOUSE MODEL
    Bessede, Alban
    Guegan, Jean Philippe
    Nafia, Imane
    Chaibi, Assia
    Rey, Christophe
    Ngouala, Oren
    Peyraud, Florent
    Italiano, Antoine
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1484 - A1484
  • [4] Mechanisms of anti-PDL1 resistance
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2018, 15 (04) : 201 - 201
  • [5] Mechanisms of anti-PDL1 resistance
    Clemens Thoma
    Nature Reviews Urology, 2018, 15 : 201 - 201
  • [6] Targeting immunotherapy to the tumor microenvironment using anti-PDL1 VHH
    Dougan, Michael
    Ingram, Jessica
    Ploegh, Hidde
    Dougan, Stephanie K.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [7] A novel anti-PDL1 x anti-VEGFR2 bispecific antibody for enhanced antitumor immunity
    Lu, Dan
    Polonskaya, Zhanna
    Zhang, Haifan
    Luna, Xenia
    Martomo, Stella
    Zhang, Zhikai
    Zhong, Zhaojing
    Wu, Yan
    Patel, Jeegar
    Tonra, James
    Witte, Larry
    Waksal, Sam
    Zhu, Zhenping
    CANCER RESEARCH, 2016, 76
  • [8] HOST MYELOID RESPONSE TO TUMOR AND IMMUNOTHERAPY IS ASSOCIATED WITH HETEROGENEITY IN OUTCOMES TO ANTI-PDL1
    Hanna, Ann
    Sun, Xiaopeng
    Gonzalez-Ericsson, Paula
    Sanchez, Violeta
    Sanders, Melinda
    Balko, Justin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A264 - A264
  • [9] Host myeloid response to tumor and immunotherapy is associated with heterogeneity in outcomes to anti-PDL1
    Hanna, Ann
    Sun, Xiaopeng
    Gonzalez-Ericsson, Paula I.
    Sanchez, Violeta M.
    Sanders, Melinda E.
    Balko, Justin M.
    CANCER RESEARCH, 2022, 82 (04)
  • [10] Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1
    Liu, Hsuan-Chen
    Viswanath, Dixita I.
    Pesaresi, Federica
    Xu, Yitian
    Zhang, Licheng
    Di Trani, Nicola
    Paez-Mayorga, Jesus
    Hernandez, Nathanael
    Wang, Yu
    Erm, Donald R.
    Ho, Jeremy
    Susnjar, Antonia
    Liu, Xuewu
    Demaria, Sandra
    Chen, Shu-Hsia
    Teh, Bin S.
    Butler, Edward Brian
    Chua, Corrine Ying Xuan
    Grattoni, Alessandro
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (02): : 492 - 506
12345